SCHEMBL17975293

SCHEMBL17975293

CCCCCc1c2c(cc(C)c1C(=O)O)OC(=O)c1c(cc(C)cc1C(=O)CCCC)O2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.67
MAPT P10636 3/20 0.67
RECQL P46063 3/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
POLB P06746 2/20 0.67
CYP3A4 P08684 1/20 0.67
MAPK1 P28482 1/20 0.67
HSD17B10 Q99714 1/20 0.67
GPR35 Q9HC97 1/20 0.67
SLCO1B3 Q9NPD5 1/20 0.67
SAE1 Q9UBE0 1/20 0.67
UBA2 Q9UBT2 1/20 0.67
SLCO1B1 Q9Y6L6 1/20 0.67
KIF20B Q96Q89 2/20 0.58
KDM4E B2RXH2 1/20 0.52
PTGES O14684 1/20 0.52
GAA P10253 1/20 0.52
BLM P54132 1/20 0.52
CENPE Q02224 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15294483 0.91 PTPN1 (0.80) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL15294481 0.85 PTPN1 (0.69) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL18351635 0.85 MAPT (0.70) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL17975305 0.84 MAPT (0.69) PTPN1MAPTRECQLMEN1KMT2A
Lobaric Acid SCHEMBL3910434 0.81 PTPN1 (1.00) PTPN1MAPTRECQLMEN1KMT2A
Lobaric Acid SCHEMBL29431924 0.81 PTPN1 (1.00) PTPN1MAPTRECQLMEN1KMT2A
Lobaric Acid SCHEMBL29788372 0.81 PTPN1 (1.00) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL15178484 0.78 PTPN1 (0.80) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL14703230 0.77 PTPN1 (0.93) PTPN1MAPTRECQLMEN1KMT2A
SCHEMBL17975296 0.76 MAPT (0.69) PTPN1MAPTRECQLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-12-29 US disclosed
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G PTPN1 1794/4885MAPT 1595/4885RECQL 2796/4885
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G PTPN1 1794/4885MAPT 1595/4885RECQL 2796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.